MAX Surgical Specialty Management Appoints Dr. Jason M. Auerbach CEO, Promotes Jeffrey DeBellis

MAX Surgical Specialty Management (MAX), a platform for oral and maxillofacial surgery (OMS) in the Northeast, announced leadership changes aimed at supporting its next phase of growth. Dr. Jason M. Auerbach, who founded MAX in 2022, has been appointed Chief Executive Officer. Jeffrey DeBellis has been promoted to President and Chief Operating Officer, and Jeffrey Couper continues as Chief Financial Officer.

The leadership realignment occurs as MAX supports over 50 surgeons across more than 40 locations in New Jersey, New York, Pennsylvania, Connecticut, and Vermont. The company is also accelerating partnerships with independent OMS practices throughout the region.

"MAX was built on a simple idea: surgeons deserve a partner who understands this specialty from the inside, because we live it every day," said Dr. Jason M. Auerbach. "This structure lets each of us lead from our strength. I stay closest to the clinical and cultural core of what we're building. Jeff runs the operating engine that lets our practices grow without losing what makes them exceptional. Our surgeons get the best of both."

In his role as President and COO, DeBellis will oversee day-to-day operations across MAX's partner practices, deepening the operational infrastructure supporting the platform's growth. "Jason's clinical credibility is the foundation this company is built on, and that hasn't changed," DeBellis stated. "What's changed is that we now have the structure to match our ambitions."

The company states it provides institutional-grade support in operations, finance, marketing, human resources, and revenue cycle management, while partner practices maintain full clinical autonomy. MAX emphasizes that optimal patient outcomes begin with surgeons who are supported, not managed from afar.